Literature DB >> 8789863

The topography of bilateral retinoblastoma lesions.

D H Abramson1, D S Gombos.   

Abstract

PURPOSE: The anatomic location of intraocular retinoblastoma foci was investigated in patients with bilateral retinoblastoma. The study was designed to evaluate the retinal topography of intraocular tumors and their time course of presentation.
METHODS: A retrospective study of 565 eyes with bilateral retinoblastoma was conducted. Data included patient age at detection of each tumor and tumor location within the retina. Intraocular location was characterized in three ways: 1) superior versus inferior retina; 2) nasal versus temporal retina; and 3) macular to peripheral retina, defined as four circular zones.
RESULTS: There was a direct correlation between patient age at tumor detection and retinal topography. This relationship followed a central-to-peripheral distribution, with macular tumors presenting earliest and anterior retinal tumors presenting last. Twenty-nine (100%) macular tumors were detected at the time of initial diagnosis, and none presented after 15.5 months of age. When controlled for surface area tumors were located equally in all circular zones.
CONCLUSION: There is a time course in which tumors in different parts of the retina come to clinical presentation. All macular tumors in this study and the majority of tumors in the posterior pole were detected before age 24 months. The authors provide possible explanations for these findings and their implications for treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8789863     DOI: 10.1097/00006982-199616030-00009

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  12 in total

1.  Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification.

Authors:  David MacPherson; Karina Conkrite; Mandy Tam; Shizuo Mukai; David Mu; Tyler Jacks
Journal:  EMBO J       Date:  2007-01-18       Impact factor: 11.598

2.  Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands.

Authors:  S M Imhof; A C Moll; A Y N Schouten-van Meeteren
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

3.  Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.

Authors:  Xiaoliang L Xu; Yuqiang Fang; Thomas C Lee; Douglas Forrest; Cheryl Gregory-Evans; Dena Almeida; Aihong Liu; Suresh C Jhanwar; David H Abramson; David Cobrinik
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

4.  Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells.

Authors:  David Cobrinik; Richard O Francis; David H Abramson; Thomas C Lee
Journal:  Mol Cancer       Date:  2006-12-12       Impact factor: 27.401

5.  Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.

Authors:  Bhavna Chawla; Amit Jain; Rachna Seth; Rajvardhan Azad; V K Mohan; Neelam Pushker; Supriyo Ghose
Journal:  Indian J Ophthalmol       Date:  2016-07       Impact factor: 1.848

6.  Unusually very late-onset new growth of intraocular retinoblastoma: A case report and review of literature.

Authors:  Yeshigeta Gelaw; Shoeib Mohamed Shoukry; Ihab Saad Othman
Journal:  Am J Ophthalmol Case Rep       Date:  2016-12-28

7.  Insights from mouse models into human retinoblastoma.

Authors:  David Macpherson
Journal:  Cell Div       Date:  2008-05-19       Impact factor: 5.130

8.  Spatiotemporal Patterns of Tumor Occurrence in Children with Intraocular Retinoblastoma.

Authors:  Benjamin A King; Carlos Parra; Yimei Li; Kathleen J Helton; Ibrahim Qaddoumi; Matthew W Wilson; Robert J Ogg
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

9.  Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.

Authors:  David A Camp; Lauren A Dalvin; Rachel Schwendeman; Li-Anne S Lim; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

10.  Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.

Authors:  Irsan E Kooi; Berber M Mol; Annette C Moll; Paul van der Valk; Marcus C de Jong; Pim de Graaf; Saskia E van Mil; Antoinette Y N Schouten-van Meeteren; Hanne Meijers-Heijboer; Gertjan L Kaspers; Hein Te Riele; Jacqueline Cloos; Josephine C Dorsman
Journal:  EBioMedicine       Date:  2015-07-08       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.